Monday, May 16, 2022

India ready to pay damages to Pfizer and Moderna against legal proceedings: Sources

New Delhi: Central government sources said that foreign corona virus vaccine manufacturers Pfizer and Moderna may get damages against legal proceedings in India, as companies in other countries have been given this facility.

Health ministry sources suggested that damages against the liability requested by vaccine makers Pfizer and Moderna in India should not be an issue and it would be given to them (as in other countries including the United States).

“If these companies have applied for emergency use authorization in India, then we are ready to compensate them,” the sources said. “Hopefully, they will be compensated against legal proceedings similar to what has been allowed in other countries for Pfizer and Moderna,” he said.

Pfizer cannot be sued for any adverse effect in countries like the US. India has so far not given any such exemption to any manufacturer against the cost of compensation for any serious side effect.

Read Also:  Son's Trouble and Financial Despair Marks USC Corruption Case

But despite these concessions, it will take some time for Pfizer and Moderna to join India’s vaccine program, as there is a huge demand for COVID shots around the world.

According to reports, Cipla had requested Trial and Customs-related compensation and several exemptions for Pfizer. Like Moderna, Pfizer has insisted on damages, as it has demanded in every country that has supplied the vaccines.

Significantly, the central government has so far refused to pay damages to any vaccine manufacturer.

Cipla on Tuesday said it is close to giving Moderna an advance of over Rs 1 billion as it seeks to procure 50 million doses by 2022. Pfizer has already said that it is ready to offer 50 million doses to India between July and October this year.

Read Also:  West Bengal Result 2021: TMC leads in more than 200 seats in trends, know margin of votes in Shuvendu-Mamta in Nandigram

Other foreign vaccines like Pfizer, Moderna one step closer with DCGI exemption
Meanwhile, the Drug Controller General of India (DCGI) has finished specific trials of COVID-19 vaccines that have received approvals by other international regulatory bodies – likely to pave the way for foreign vaccines for the country’s urgent need. It’s a big step.

DGGI chief VG Somani said this would apply to vaccines that have already been approved for use by the US FDA, EMA, UK MHRA, PMDA Japan or are listed for emergency use by the World Health Organisation.

.

Nation World News Desk
Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -